NEULANDLAB.BONEULANDLAB.BOBSE
Loading
EBITDA Margin Over TimeStrong
Percentile Rank93
3Y CAGR+23.2%
5Y CAGR+16.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+23.2%/yr
vs +12.3%/yr prior
5Y CAGR
+16.7%/yr
Recent acceleration
Acceleration
+11.0pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
202528.45%-6.6%
202430.46%+26.7%
202324.05%+58.1%
202215.21%-13.7%
202117.63%+34.2%
202013.14%+51.2%
20198.69%-9.3%
20189.57%-45.1%
201717.44%+21.0%
201614.41%-